Literature DB >> 19727150

Psychological aspects of PSA testing.

Riccardo G V Torta1, Jacopo Munari.   

Abstract

The process of PSA screening and subsequent monitoring of PSA levels may represent a great source of emotional distress to patients, the majority of whom are not adequately informed about the screening process and the implications of an abnormal result. The need remains for education of patients on the subject, but no consensus has been reached as to the content of information men should be offered. Helping patients to attribute a different meaning to a potentially stressful event can avoid the development of emotional distress, and physicians can have an important role in this process. Informing patients is essential to allow the development of positive coping styles, and establishing good doctor-patient communication leads to improved compliance and the improvement of patients' psychological wellbeing.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19727150     DOI: 10.1038/nrurol.2009.146

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


  23 in total

Review 1.  Part 2: Patient information, informed decision-making and the psycho-social impact of prostate-specific antigen testing.

Authors:  Paul Hewitson; Joan Austoker
Journal:  BJU Int       Date:  2005-04       Impact factor: 5.588

Review 2.  Should men over the age of 65 years receive PSA screening? Argument against.

Authors:  Peter C Albertsen
Journal:  Nat Clin Pract Urol       Date:  2008-03-18

Review 3.  Should men over the age of 65 years receive PSA screening? Argument in favor.

Authors:  Jared M Whitson; Badrinath R Konety
Journal:  Nat Clin Pract Urol       Date:  2008-03-18

4.  Awareness of prostate cancer among the general public: findings of an independent international survey.

Authors:  Claude C Schulman; Roger Kirby; John M Fitzpatrick
Journal:  Eur Urol       Date:  2003-09       Impact factor: 20.096

5.  "PSA-itis": knowledge of serum prostate specific antigen and other causes of anxiety in men with metaststic prostate cancer.

Authors:  Aisha Lofters; Helen G Juffs; Gregory R Pond; Ian F Tannock
Journal:  J Urol       Date:  2002-12       Impact factor: 7.450

6.  Do general practitioners use prostate-specific antigen as a screening test for early prostate cancer?

Authors:  J E Ward; L Gupta; N J Taylor
Journal:  Med J Aust       Date:  1998-07-06       Impact factor: 7.738

7.  Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy?

Authors:  Rhiannon C Macefield; J Athene Lane; Chris Metcalfe; Liz Down; David E Neal; Freddie C Hamdy; Jenny L Donovan
Journal:  Eur J Cancer       Date:  2009-04-16       Impact factor: 9.162

8.  Discussion about switch strategy in the adjuvant hormonal therapy of breast cancer: psychological aspects of physician-patient communication.

Authors:  A Costantini; A Picardi; M Zilli; F Cairoli; R Torta; P Marchetti; W Baile; S Iacobelli
Journal:  Ann Oncol       Date:  2009-06-01       Impact factor: 32.976

9.  Anxiety associated with prostate cancer screening with special reference to men with a positive screening test (elevated PSA) - Results from a prospective, population-based, randomised study.

Authors:  Sigrid Carlsson; Gunnar Aus; Catrin Wessman; Jonas Hugosson
Journal:  Eur J Cancer       Date:  2007-07-23       Impact factor: 9.162

10.  Short-term effects of population-based screening for prostate cancer on health-related quality of life.

Authors:  M L Essink-Bot; H J de Koning; H G Nijs; W J Kirkels; P J van der Maas; F H Schröder
Journal:  J Natl Cancer Inst       Date:  1998-06-17       Impact factor: 13.506

View more
  3 in total

1.  Signs and symptoms in relation to progression, experiences of an uncertain illness situation in men with metastatic castration-resistant prostate cancer-A qualitative study.

Authors:  Ulrika Rönningås; Maja Holm; Sandra Doveson; Per Fransson; Lars Beckman; Agneta Wennman-Larsen
Journal:  Eur J Cancer Care (Engl)       Date:  2022-04-12       Impact factor: 2.328

2.  Prostate specific antigen testing is associated with men's psychological and physical health and their healthcare utilisation in a nationally representative sample: a cross-sectional study.

Authors:  Evelyn M Flahavan; Frances J Drummond; Kathleen Bennett; Thomas I Barron; Linda Sharp
Journal:  BMC Fam Pract       Date:  2014-06-17       Impact factor: 2.497

3.  Perceptions about screening for prostate cancer using genetic lifetime risk assessment: a qualitative study.

Authors:  Pia Kirkegaard; Adrian Edwards; Trine Laura Overgaard Nielsen; Torben Falck Ørntoft; Karina Dalsgaard Sørensen; Michael Borre; Flemming Bro
Journal:  BMC Fam Pract       Date:  2018-02-17       Impact factor: 2.497

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.